课题基金 / 基金详情

A non-inferiority trial of cytisine versus varenicline for smoking cessation.

A non-inferiority trial of cytisine versus varenicline for smoking cessation.
金雀花碱与伐尼克兰戒烟的非劣效性试验。
批准号:
nhmrc : GNT1108318
负责人:
A/Pr Coral Gartner
金额:
$188.58万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2016
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2016-01-01 至 --

项目摘要

项目成果

A/Pr Coral Gartner的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Long-term quit rates via existing behavioural and pharmacological approaches to smoking cessation remain low and there is a need for further evidence-based treatments to complement standard treatment. We will conduct a large-scale trial to demonstrate the cost-effectiveness of cytisine compared to existing varenicline treatment. The findings will have direct health care system implications and cytisine, if effective, has the potential to save millions of lives globally.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Pragmatic Randomised Clinical Trial of Nicotine Vaporisers added to Smoking Cessation Treatment for Priority Populations Living with Comorbidities
  • 批准号:
    nhmrc : 1124264
  • 项目类别:
    Project Grants
  • 资助金额:
    $102.37万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Coral Gartner
  • 依托单位:
Adding an electronic-cigarette to standard behavioural treatment for low-socioeconomic status smokers: A randomised trial.
  • 批准号:
    nhmrc : 1127390
  • 项目类别:
    Project Grants
  • 资助金额:
    $94.38万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Coral Gartner
  • 依托单位:
Adding an electronic-cigarette to standard behavioural treatment for low-socioeconomic status smokers: A randomised trial.
  • 批准号:
    nhmrc : GNT1127390
  • 项目类别:
    Project Grants
  • 资助金额:
    $138.11万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Coral Gartner
  • 依托单位:
A Pragmatic Randomised Clinical Trial of Nicotine Vaporisers added to Smoking Cessation Treatment for Priority Populations Living with Comorbidities
  • 批准号:
    nhmrc : GNT1124264
  • 项目类别:
    Project Grants
  • 资助金额:
    $149.91万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Coral Gartner
  • 依托单位:
海外基金